Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 208 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Tziomalos, Konstantinos [Clear All Filters]
The Effect of Proprotein Convertase Subtilisin-Kexin Type 9 and its Inhibition on Glucose Metabolism and Cardiovascular Risk. We Should do Better the Second Time After Statins..
Curr Pharm Des. 23(10), 1477-1483.
(2017). Efficacy of Administration of an Angiotensin Converting Enzyme Inhibitor for Two Years on Autonomic and Peripheral Neuropathy in Patients with Diabetes Mellitus..
J Diabetes Res. 2017, 6719239.
(2017). Impaired kidney function evaluated with the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is associated with more severe acute ischemic stroke..
Vasc Med. 22(5), 432-434.
(2017). An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)..
Hormones (Athens). 16(3), 200-204.
(2017). An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)..
Hormones (Athens). 16(3), 306-312.
(2017). Novel treatment options for the management of heterozygous familial hypercholesterolemia..
Expert Rev Clin Pharmacol. 10(12), 1375-1381.
(2017). Prevalence and geographic variation of abdominal obesity in 7- and 9-year-old children in Greece; World Health Organization Childhood Obesity Surveillance Initiative 2010..
BMC Public Health. 17(1), 126.
(2017). Prevalence, etiology and management of non-alcoholic fatty liver disease in patients with polycystic ovary syndrome..
Minerva Endocrinol. 42(2), 122-131.
(2017). Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome..
Hormones (Athens). 16(4), 373-380.
(2017). Prognostic significance of major lipids in patients with acute ischemic stroke..
Metab Brain Dis. 32(2), 395-400.
(2017). Role of lipid-lowering agents in the management of diabetic retinopathy..
World J Diabetes. 8(1), 1-6.
(2017). The Role of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in the Management of Dyslipidemia..
Curr Pharm Des. 23(10), 1495-1499.
(2017). Stress hyperglycemia and acute ischemic stroke in-hospital outcome..
Metabolism. 67, 99-105.
(2017).
(2017). The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
Metabolism. 71, 17 - 32.
(2017). Vascular calcification: the role of microRNAs..
Biomol Concepts. 8(2), 119-123.
(2017). Acenocoumarol vs. low-dose dabigatran in real-world patients discharged after ischemic stroke..
Blood Coagul Fibrinolysis. 27(2), 185-9.
(2016). Adequacy of preadmission oral anticoagulation with vitamin K antagonists and ischemic stroke severity and outcome in patients with atrial fibrillation..
J Thromb Thrombolysis. 41(2), 336-42.
(2016). Adherence to antihyperglycemic treatment: a work in progress..
Expert Opin Pharmacother. 17(12), 1579-80.
(2016). Editorial: Vascular Calcification, Cardiovascular Risk and microRNAs..
Curr Vasc Pharmacol. 14(2), 208-10.
(2016). Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease..
World J Gastroenterol. 22(41), 9039-9043.
(2016). Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors..
Hormones (Athens). 15(1), 8-14.
(2016). High-density lipoprotein: quantity or quality?.
J Thorac Dis. 8(11), 2975-2977.
(2016). The role of adipokines in ischemic stroke risk stratification..
Int J Stroke. 11(4), 389-98.
(2016). Treatment with Clopidogrel Prior to Acute Non-Cardioembolic Ischemic Stroke Attenuates Stroke Severity..
Cerebrovasc Dis. 41(5-6), 226-32.
(2016).